Concepedia

Zhanna Sobol

ZS

Statistics

Publications

13

Citations

637

H-Index

12

Active since

2007

Affiliations

Pfizer (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of California, Los Angeles

Bayer (Germany)

Gilead Sciences (United States)

Zhanna Sobol is an author at Pfizer (United States) specializing in pharmacy, toxicology, and genotoxicity mechanisms.

Publications per year

2007–2025

13

Publications

13

Discovery of a Clinical Candidate from the Structurally Unique Dioxa-bicyclo[3.2.1]octane Class of Sodium-Dependent Glucose Cotransporter 2 Inhibitors

Vincent Mascitti, Tristan S. Maurer, Ralph P. Robinson et al. · Journal of Medicinal Chemistry · 2011 · 134 citations · Full text

, , +17

Synthesis, Molecular Editing, and Biological Assessment of the Potent Cytotoxin Leiodermatolide

Damien Mailhol, Jens Willwacher, Nina Kausch‐Busies et al. · Journal of the American Chemical Society · 2014 · 94 citations

, , +16

Genotoxicity profiles of common alkyl halides and esters with alkylating activity

Zhanna Sobol, Maria Engel, Elizabeth Rubitski et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2007 · 72 citations

, , +12

N-acetyl cysteine protects against ionizing radiation-induced DNA damage but not against cell killing in yeast and mammals

Ramune Reliene, Julianne M. Pollard, Zhanna Sobol et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 2009 · 56 citations

, , +14

Intracellular and extracellular factors influencing Cr(VI and Cr(III) genotoxicity

Zhanna Sobol, Robert H. Schiestl · Environmental and Molecular Mutagenesis · 2011 · 53 citations

, , +15

1–5 of 13